{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:29:24Z","timestamp":1779247764823,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00259-020-04694-1","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T22:02:17Z","timestamp":1579557737000},"page":"2142-2154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET\/MR in patients referred for diagnosis of dementia"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9516","authenticated-orcid":false,"given":"Jenny","family":"Ceccarini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatienne","family":"Van Weehaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolien","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sunaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"4694_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/d41586-018-05718-5","volume":"559","author":"L Drew","year":"2018","unstructured":"Drew L. An age-old story of dementia. Nature. 2018;559:S2\u20133.","journal-title":"Nature"},{"key":"4694_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer\u2019s Dement. 2013;9:63\u201375.e2.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4694_CR3","unstructured":"Shivamurthy VK, Tahari AK, Marcus C, Subramaniam RM, Vkn S. Brain FDG PET and the diagnosis of dementia."},{"key":"4694_CR4","unstructured":"Amy Orciari Herman PFW. For patients with cognitive impairment, amyloid PET leads to changes in clinical management. NEJM J Watch. 2019;2019."},{"key":"4694_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.semnuclmed.2016.09.006","volume":"47","author":"VL Villemagne","year":"2017","unstructured":"Villemagne VL, Dor\u00e9 V, Bourgeat P, Burnham SC, Laws S, Salvado O, et al. A\u03b2-amyloid and tau imaging in dementia. Semin Nucl Med. 2017;47:75\u201388.","journal-title":"Semin Nucl Med"},{"key":"4694_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.arr.2015.12.010","volume":"30","author":"N Okamura","year":"2016","unstructured":"Okamura N, Harada R, Furumoto S, Tago T, Yanai K, Arai H, et al. Advances in the development of tau PET radiotracers and their clinical applications. Ageing Res Rev. 2016;30:107\u201313.","journal-title":"Ageing Res Rev"},{"key":"4694_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.semnuclmed.2016.09.005","volume":"47","author":"A Mallik","year":"2017","unstructured":"Mallik A, Drzezga A, Minoshima S. Clinical amyloid imaging. Semin Nucl Med. 2017;47:31\u201343.","journal-title":"Semin Nucl Med"},{"key":"4694_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00259-015-3098-2","volume":"42","author":"S Morbelli","year":"2015","unstructured":"Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Ch\u00e9telat G, Drezgza A, et al. A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives. Eur J Nucl Med Mol Imaging. 2015;42:1487\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4694_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neurobiolaging.2016.03.033","volume":"52","author":"V Garibotto","year":"2017","unstructured":"Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, et al. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework. Neurobiol Aging. 2017;52:183\u201395.","journal-title":"Neurobiol Aging"},{"key":"4694_CR10","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain. 2007;130:2616\u201335.","journal-title":"Brain"},{"key":"4694_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/acn3.330","volume":"3","author":"D Tosun","year":"2016","unstructured":"Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, et al. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Ann Clin Transl Neurol. 2016;3:740\u201351.","journal-title":"Ann Clin Transl Neurol"},{"key":"4694_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/nimg.1995.1017","volume":"2","author":"M Jueptner","year":"1995","unstructured":"Jueptner M, Weiller C. Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage. 1995;2:148\u201356.","journal-title":"Neuroimage"},{"key":"4694_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1212\/01.wnl.0000238163.71349.78","volume":"67","author":"AT Du","year":"2006","unstructured":"Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215\u201320.","journal-title":"Neurology"},{"key":"4694_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3174\/ajnr.A1955","volume":"31","author":"CA Raji","year":"2010","unstructured":"Raji CA, Lee C, Lopez OL, Tsay J, Boardman JF, Schwartz ED, et al. Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol. 2010;31:847\u201355.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4694_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12883-017-0870-x","volume":"17","author":"T Kaneta","year":"2017","unstructured":"Kaneta T, Katsuse O, Hirano T, Ogawa M, Shihikura-Hino A, Yoshida K, et al. Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer\u2019s disease: a cross-sectional study. BMC Neurol. 2017;17:91.","journal-title":"BMC Neurol"},{"key":"4694_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/nbm.1792","volume":"25","author":"P Liu","year":"2012","unstructured":"Liu P, Uh J, Devous MD, Adinoff B, Lu H. Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography. NMR Biomed. 2012;25:779\u201386.","journal-title":"NMR Biomed"},{"key":"4694_CR17","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1007\/s00330-017-4784-1","volume":"27","author":"D F\u00e4llmar","year":"2017","unstructured":"F\u00e4llmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, et al. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. Eur Radiol. 2017;27:4237\u201346.","journal-title":"Eur Radiol"},{"key":"4694_CR18","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00330-015-3696-1","volume":"25","author":"SCJ Verfaillie","year":"2015","unstructured":"Verfaillie SCJ, Adriaanse SM, Binnewijzend MAA, Benedictus MR, Ossenkoppele R, Wattjes MP, et al. Cerebral perfusion and glucose metabolism in Alzheimer\u2019s disease and frontotemporal dementia: two sides of the same coin? Eur Radiol. 2015;25:3050\u20139.","journal-title":"Eur Radiol"},{"key":"4694_CR19","first-page":"405","volume":"17","author":"UC Anazodo","year":"2018","unstructured":"Anazodo UC, Finger E, Kwan BYM, Pavlosky W, Warrington JC, G\u00fcnther M, et al. Using simultaneous PET\/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET. Neuro Image Clin. 2018;17:405\u201314.","journal-title":"Neuro Image Clin"},{"key":"4694_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1148\/radiol.2018170575","volume":"288","author":"I Riederer","year":"2018","unstructured":"Riederer I, Bohn KP, Preibisch C, Wiedemann E, Zimmer C, Alexopoulos P, et al. Alzheimer disease and mild cognitive impairment: integrated pulsed arterial spin-labeling MRI and 18 F-FDG PET. Radiology. 2018;288:198\u2013206.","journal-title":"Radiology"},{"key":"4694_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2017.05.008","volume":"45","author":"K Weyts","year":"2017","unstructured":"Weyts K, Vernooij M, Steketee R, Valkema R, Smits M. Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage dementia: comparison of arterial spin labelling MRI and FDG PET-CT in suspected dementia. Clin Imaging. 2017;45:1\u20137.","journal-title":"Clin Imaging"},{"key":"4694_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jalz.2011.06.003","volume":"8","author":"ES Musiek","year":"2012","unstructured":"Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, et al. Direct comparison of FDG-PET and ASL-MRI in Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:51\u20139.","journal-title":"Alzheimers Dement"},{"key":"4694_CR23","doi-asserted-by":"publisher","first-page":"A83","DOI":"10.1186\/2197-7364-2-S1-A83","volume":"2","author":"D Douglas","year":"2015","unstructured":"Douglas D, Goubran M, Wilson E, Xu G, Tripathi P, Holley D, et al. Correlation between arterial spin labeling MRI and dynamic FDG on PET-MR in Alzheimer\u2019s disease and non-Alzhiemer\u2019s disease patients. EJNMMI Phys. 2015;2:A83.","journal-title":"EJNMMI Phys"},{"key":"4694_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224\u201347.","journal-title":"Hum Brain Mapp"},{"key":"4694_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2967\/jnumed.111.096578","volume":"53","author":"NI Bohnen","year":"2012","unstructured":"Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med. 2012;53:59\u201371.","journal-title":"J Nucl Med"},{"key":"4694_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3174\/ajnr.A1030","volume":"29","author":"AR Deibler","year":"2008","unstructured":"Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol. 2008;29:1228\u201334.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4694_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00234-015-1571-z","volume":"57","author":"M Grade","year":"2015","unstructured":"Grade M, Hernandez Tamames JA, Pizzini FB, Achten E, Golay X, Smits M. A neuroradiologist\u2019s guide to arterial spin labeling MRI in clinical practice. Neuroradiology. 2015;57:1181\u2013202.","journal-title":"Neuroradiology"},{"key":"4694_CR28","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3174\/ajnr.A1562","volume":"30","author":"T Yoshiura","year":"2009","unstructured":"Yoshiura T, Hiwatashi A, Yamashita K, Ohyagi Y, Monji A, Takayama Y, et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. Am J Neuroradiol. 2009;30:1388\u201393.","journal-title":"Am J Neuroradiol"},{"key":"4694_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainresbull.2018.05.004","volume":"140","author":"X Tang","year":"2018","unstructured":"Tang X, Cai F, Ding D-X, Zhang L-L, Cai X-Y, Fang Q. Magnetic resonance imaging relaxation time in Alzheimer\u2019s disease. Brain Res Bull. 2018;140:176\u201389.","journal-title":"Brain Res Bull"},{"key":"4694_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1212\/WNL.0b013e31823a0ef7","volume":"77","author":"Y Chen","year":"2011","unstructured":"Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 2011;77:1977\u201385.","journal-title":"Neurology"},{"key":"4694_CR31","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging. 2003;30:1104\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4694_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/jon.12296","volume":"26","author":"D F\u00e4llmar","year":"2016","unstructured":"F\u00e4llmar D, Lilja J, Velickaite V, Danfors T, Lubberink M, Ahlgren A, et al. Visual assessment of brain perfusion MRI scans in dementia: a pilot study. J Neuroimaging. 2016;26:324\u201330.","journal-title":"J Neuroimaging"},{"key":"4694_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/jon.12264","volume":"26","author":"S Verclytte","year":"2016","unstructured":"Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, et al. Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG-PET in early-onset Alzheimer\u2019s disease. J Neuroimaging. 2016;26:207\u201312.","journal-title":"J Neuroimaging"},{"key":"4694_CR34","doi-asserted-by":"crossref","unstructured":"Teune LK, Renken Phd RJ, De Jong BM, Willemsen AT, Van Osch MJ, Roerdink JBTM, et al. Parkinson\u2019s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. 2014;","DOI":"10.1016\/j.nicl.2014.06.007"},{"key":"4694_CR35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"GD Rabinovici","year":"2019","unstructured":"Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321:1286.","journal-title":"JAMA"},{"key":"4694_CR36","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/jmri.23579","volume":"35","author":"OM Henriksen","year":"2012","unstructured":"Henriksen OM, Larsson HBW, Hansen AE, Gr\u00fcner JM, Law I, Rostrup E. Estimation of intersubject variability of cerebral blood flow measurements using MRI and positron emission tomography. J Magn Reson Imaging. 2012;35:1290\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"4694_CR37","doi-asserted-by":"crossref","unstructured":"Schramm G, Koole M, Willekens SMA, Rezaei A, Van Weehaeghe D, Delso G, et al. Regional accuracy of ZTE-based attenuation correction in static and dynamic brain PET\/MR. \u200eMed Phys. 2018.","DOI":"10.3389\/fphy.2019.00211"},{"key":"4694_CR38","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2009.11.008","volume":"32","author":"LK Ferreira","year":"2011","unstructured":"Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer\u2019s disease: a meta-analysis of VBM studies. Neurobiol Aging. 2011;32:1733\u201341.","journal-title":"Neurobiol Aging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-020-04694-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:13:45Z","timestamp":1611015225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-020-04694-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4694"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04694-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}